Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Marcelo Henrique NapimogaE P RochaC A Trindade-da-SilvaA P D DemasiE F MartinezC G MacedoH B AbdallaA BettaiebF G HajJ T Clemente-NapimogaB InceogluB D HammockPublished in: Journal of periodontal research (2018)
The sEH inhibitor, TPPU, showed immunomodulatory effects, decreasing bone resorption and inflammatory responses in a bone resorption mouse model.